[BCT] YoY Quarter Result on 31-Oct-2023 [#Q1]

Stock
[BCT] BriaCell Therapeutics Corp.
Announcement Date
30-Oct-2023
Financial Year
2024
Quarter
31-Oct-2023 [#Q1]
Profit Trend
QoQ- 348.12%
YoY- 88.15%
Quarter Report
BCT's Result
BCT's Financial Summary
View:
Show?
Quarter Result
31/10/24 31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -5,829 5,959 -1,107 891 234 417 -798 39.25%
Tax 0 -14,505 -4,297 -107 -14 -75 199 -
NP -5,802 6,002 3,190 891 234 417 -798 39.14%
Tax Rate - 243.41% - 11.98% 6.20% 18.03% - -
Total Cost 5,802 -6,002 -3,190 -891 -234 -417 798 39.14%
Ratio Analysis
31/10/24 31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/10/24 31/10/23 31/10/22 31/10/21 31/10/20 31/10/19 31/10/18 CAGR
EPS -0.32 0.38 0.21 0.06 0.30 0.58 -1.48 -22.50%
EPS Diluted -0.32 -0.50 0.21 0.06 0.30 0.58 -1.48 -22.50%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.